Report Cover

ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028


MARKET OUTLOOK
Triton Market Research envisions that the Asia-Pacific market for digital genome would witness a CAGR of 10.52% over the forecasting period from 2021 to 2028.
China, India, Japan, South Korea, Australia & New Zealand, ASEAN countries, and Rest of APAC together shape the market in this region.
India is working on a human genome diversity project under the Department of Biotechnology?s (DBT) human genetics program. This project was initiated way back in November 1999, at the Indian Institute of Chemical Biology (IICB), the Indian Statistical Institute (ISI), and the Saha Institute of Nuclear Physics (SINP). Post this, the nation?s biotechnology sector experienced a boom, along with great changes and developments.
In January 2020, DBT sanctioned the Genome India Project (GIP). Under this project, a collaboration of 20 institutions, consisting of the Indian Institute of Science and some IITs, among others, will enable new efficiencies in life sciences, medicine, and agriculture. The project is aimed at developing a ?reference genome,? so as to understand and analyze diseases and traits in the diverse Indian population. The GIP will also help develop personalized medicine, anticipate diseases, and provide treatment as per the patients? genome.
It can be seen that the Government of Indian is investing and initiating programs for developing genomic technology. The rise in support from the government to enhance the biotechnology sector is expected to boost India?s digital genome market over the forecasting period.
COMPETITIVE OUTLOOK
Major players engaged in this market include Agilent Technologies Inc., Qiagen NV, Pacific Bioscience, Biomerieux SA, F. Hoffmann-La Roche, Regeneron Pharmaceuticals, and Bio-Rad Laboratories Inc.
TABLE OF CONTENTS 
1. ASIA-PACIFIC DIGITAL GENOME MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. PORTER?S FIVE FORCES MODEL
2.1.1. THREAT OF NEW ENTRANTS
2.1.2. THREAT OF SUBSTITUTE PRODUCTS
2.1.3. BARGAINING POWER OF BUYERS
2.1.4. BARGAINING POWER OF SUPPLIERS
2.1.5. COMPETITIVE RIVALRY
2.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
2.3. MARKET ATTRACTIVENESS INDEX
2.4. VENDOR LANDSCAPE
2.5. KEY INSIGHTS
2.6. KEY DRIVERS
2.6.1. PROLIFERATING BURDEN OF CHRONIC DISEASES 
2.6.2. CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENT IN THE FIELD OF GENOMICS
2.7. KEY RESTRAINTS
2.7.1. SECURITY RISKS ASSOCIATED WITH DIGITAL GENOME
2.7.2. LACK OF SKILLED PROFESSIONALS IN THE FIELD OF GENOME TECHNOLOGY
2.8. KEY OPPORTUNITIES 
2.8.1. TECHNOLOGICAL ADVANCEMENTS
2.8.2. PREVAILING AWARENESS IN THE DEVELOPING ECONOMIES REGARDING DNA SEQUENCING TECHNOLOGIES
3. DIGITAL GENOME MARKET OUTLOOK - BY PRODUCT
3.1. SEQUENCING AND ANALYZER INSTRUMENTS
3.2. DNA/RNA ANALYSIS
3.3. SEQUENCING AND ANALYSIS SOFTWARE
3.4. SEQUENCING CHIPS
3.5. SAMPLE PREP INSTRUMENTS
4. DIGITAL GENOME MARKET OUTLOOK - BY APPLICATION
4.1. DIAGNOSTICS
4.2. DRUG DISCOVERY
4.3. ACADEMIC RESEARCH
4.4. PERSONALIZED MEDICINE
4.5. AGRICULTURAL
4.6. OTHER APPLICATIONS
5. DIGITAL GENOME MARKET OUTLOOK - BY END-USER
5.1. DIAGNOSTICS AND FORENSIC LABS
5.2. ACADEMIC RESEARCH INSTITUTES
5.3. HOSPITALS
5.4. OTHER END-USERS
6. DIGITAL GENOME MARKET - ASIA-PACIFIC
6.1. COUNTRY ANALYSIS
6.1.1. CHINA
6.1.2. JAPAN
6.1.3. AUSTRALIA & NEW ZEALAND
6.1.4. INDIA
6.1.5. SOUTH KOREA
6.1.6. ASEAN COUNTRIES
6.1.7. REST OF ASIA-PACIFIC
7. COMPANY PROFILE
7.1. QIAGEN NV
7.2. OXFORD NANOPORE TECHNOLOGIES LTD
7.3. BECTON, DICKINSON, AND COMPANY (BD)
7.4. ILLUMINA INC
7.5. THERMO FISHER SCIENTIFIC INC
7.6. PACIFIC BIOSCIENCE
7.7. BIO-RAD LABORATORIES INC
7.8. F. HOFFMANN-LA ROCHE
7.9. PERKINELMER INC
7.10. REGENERON PHARMACEUTICALS
7.11. BIOMERIEUX SA
7.12. ABBOTT LABORATORIES
7.13. AGILENT TECHNOLOGIES INC.
7.14. INSCRIPTA
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES
TABLE 1: ASIA-PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR LANDSCAPE
TABLE 3: ASIA-PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC DIGITAL GENOME MARKET, BY END-USER, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

LIST OF FIGURES
FIGURE 1: ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 3: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 18: CHINA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 19: JAPAN DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 20: AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 21: INDIA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 22: SOUTH KOREA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: ASEAN COUNTRIES DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

LIST OF TABLES TABLE 1: ASIA-PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION) TABLE 2: VENDOR LANDSCAPE TABLE 3: ASIA-PACIFIC DIGITAL GENOME MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION) TABLE 4: ASIA-PACIFIC DIGITAL GENOME MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION) TABLE 5: ASIA-PACIFIC DIGITAL GENOME MARKET, BY END-USER, 2021-2028 (IN $ MILLION) TABLE 6: ASIA-PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION) LIST OF FIGURES FIGURE 1: ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 2: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION) FIGURE 3: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION) FIGURE 4: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION) FIGURE 5: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION) FIGURE 6: ASIA-PACIFIC DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION) FIGURE 7: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION) FIGURE 8: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION) FIGURE 9: ASIA-PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION) FIGURE 10: ASIA-PACIFIC DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION) FIGURE 11: ASIA-PACIFIC DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION) FIGURE 12: ASIA-PACIFIC DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION) FIGURE 13: ASIA-PACIFIC DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION) FIGURE 14: ASIA-PACIFIC DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION) FIGURE 15: ASIA-PACIFIC DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION) FIGURE 16: ASIA-PACIFIC DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION) FIGURE 17: ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 18: CHINA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 19: JAPAN DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 20: AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 21: INDIA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 22: SOUTH KOREA DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 23: ASEAN COUNTRIES DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION) FIGURE 24: REST OF ASIA-PACIFIC DIGITAL GENOME MARKET 2021-2028 (IN $ MILLION)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: Triton Market Research
Chat with us